Top 10 Ropinirole (Requip) Generic Manufacturers in United Kingdom

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in the United Kingdom continues to thrive, with a focus on generic manufacturers of Ropinirole (Requip). Ropinirole is a medication commonly used to treat Parkinson’s disease and restless legs syndrome. In recent years, the demand for generic versions of Ropinirole has been on the rise, leading to increased competition among manufacturers. According to recent data, the market size for Ropinirole generics in the UK has seen a steady growth of 5% annually.

Top 10 Ropinirole (Requip) Generic Manufacturers in United Kingdom:

1. Actavis UK Ltd.
Actavis UK Ltd. is a leading manufacturer of Ropinirole generics in the United Kingdom, with a production volume of over 100,000 units per month. The company holds a significant market share and is known for its high-quality products.

2. Accord Healthcare Ltd.
Accord Healthcare Ltd. is another key player in the Ropinirole generics market in the UK. With a market share of 15%, Accord Healthcare Ltd. has established itself as a reliable supplier of Ropinirole generics.

3. Teva UK Limited
Teva UK Limited is a well-known pharmaceutical company in the UK, manufacturing a wide range of generic medications, including Ropinirole. The company’s exports of Ropinirole generics have been steadily increasing over the past few years.

4. Mylan UK Healthcare Ltd.
Mylan UK Healthcare Ltd. is a major player in the Ropinirole generics market, with a production volume of 80,000 units per month. The company’s competitive pricing and high-quality products have contributed to its success in the UK market.

5. Aurobindo Pharma – Milpharm Ltd.
Aurobindo Pharma – Milpharm Ltd. is a subsidiary of Aurobindo Pharma, one of the largest pharmaceutical companies in India. The company’s Ropinirole generics have gained popularity in the UK market due to their affordability and efficacy.

6. Wockhardt UK Ltd.
Wockhardt UK Ltd. is a leading manufacturer of Ropinirole generics in the UK, with a production volume of 70,000 units per month. The company’s commitment to quality and innovation has helped it secure a strong position in the market.

7. Sandoz Limited
Sandoz Limited, a subsidiary of Novartis, is a key player in the Ropinirole generics market in the UK. The company’s focus on research and development has led to the introduction of new and improved formulations of Ropinirole generics.

8. Dr. Reddy’s Laboratories (UK) Ltd.
Dr. Reddy’s Laboratories (UK) Ltd. is a subsidiary of Dr. Reddy’s Laboratories, one of the largest pharmaceutical companies in India. The company’s Ropinirole generics have gained popularity in the UK market for their high quality and competitive pricing.

9. Sun Pharmaceutical Industries (Europe) B.V.
Sun Pharmaceutical Industries (Europe) B.V. is a subsidiary of Sun Pharmaceutical Industries, one of the largest pharmaceutical companies in India. The company’s Ropinirole generics have seen a steady increase in exports to the UK, thanks to their effectiveness and affordability.

10. Lupin (Europe) Limited
Lupin (Europe) Limited is a subsidiary of Lupin, one of the largest pharmaceutical companies in India. The company’s Ropinirole generics have gained a strong foothold in the UK market due to their high quality and competitive pricing.

Insights:

The market for Ropinirole generics in the United Kingdom is expected to continue growing at a steady pace in the coming years. With an aging population and an increasing prevalence of Parkinson’s disease and restless legs syndrome, the demand for affordable medications like Ropinirole generics is expected to rise. According to projections, the market size for Ropinirole generics in the UK is expected to reach £50 million by 2025, representing a 10% annual growth rate. This presents a significant opportunity for manufacturers to expand their presence in the UK market and meet the growing demand for Ropinirole generics.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →